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Abstract
Objectives: For Southern Asian countries like Pakistan, there is inadequate evidence of risk factors associated with
mortality in patients suffering from acute coronary syndrome (ACS), especially non-ST elevation ACS (NSTE-ACS)
cases. Therefore, aim of this study was to evaluate predictors of 6-months mortality of patients presenting with NSTEACS.
Methods: For this prospective observational study we recruited adult patients diagnosed with NSTE-ACS at a tertiary
cardiac center. All he patients were followed-up after six months and survival status was recorded. Logistic regression
analysis was performed for six-month mortality and odds ratio (OR) and 95% conﬁdence interval (CI) were reported.
Results: Six-month follow-up was successful for 280 patients. On univariate analysis age >65 years, increased heart
rate, cardiac arrest at presentation, Killip class II-IV at presentation, and diabetes were found to be associated with
increased risk of 6-months mortality with OR [95% CI] of 4.27 [1.9e9.58], 1.25 [1.1e1.41], 139.44 [16.9e1150.78], 68.45
[7.88e594.41], and 2.35 [1.06e5.22] respectively. On multivariable analysis Killip class II-IV at presentation, thrombolysis
in myocardial infarction (TIMI) score of >4, and global registry of acute coronary events (GRACE) score ≥150 were
found to be independent predictors of mortality after six months of NSTE-ACS with adjusted OR of 32.93 [2.65e408.8],
3.42 [1.35e8.66], and 8.43 [3.33e21.38] respectively.
Conclusions: For patients with NSTE-ACS, our study showed seven clinical parameters to be associated with an
increased risk of 6-month mortality. These included increasing age, increased heart rate, cardiac arrest at presentation,
Killip class II-IV, diabetes, TIMI score of >4 and GRACE score of >150. Thereby aiding clinicians to apply strategic and
precise interventions in monitoring these patients accordingly.
Keywords: Acute coronary syndrome, Non-ST elevation ACS, Predictors, 6-month mortality

1. Introduction

A

cute myocardial infarction (AMI) which includes ST elevation myocardial infarction
(STEMI) and non-ST elevation myocardial

infarction (NSTEMI), remains one of the world's
leading causes of death, although signiﬁcant
changes and developments in cardiac treatment and
its control have been made [1]. More than 8 million
individuals die from AMI every year, according to
the World Health Organization [2]. In general,
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mortality rates range dramatically from 5 to 30%
based on the patient's characteristics, the severity of
ischemic disease, the country's healthcare system,
among other factors. Patients presenting with
STEMI have higher in-hospital mortality [3], but at 6
months the mortality rate of STEMI and NSTEMI
are almost similar [4]. In Southern Asian countries,
where resources are limited, there is inadequate
evidence of risk factors associated with mortality in
patients suffering from ACS, especially NSTEMI
cases. This applies in particular to Pakistan with a
population of 212.2 million and a weak health
infrastructure [5] which leads to inadequate documentation of cardiovascular diseases and its
mortality.
Previously many studies have been conducted to
investigate the predictors of mortality of patients
presenting with AMI [6e11]. However, these studies
were taken place in western populations with presumably ideal treatment and disease control.
Several studies have showcased various clinical
characteristics of the AMI patients with their
comorbidities as predictors of cardiovascular mortality [7,8,11e14]. There is signiﬁcant evidence to
believe that in the South Asian countries like
Pakistan, conventional risk factors that are well
known in high-income countries play a similar role
in cardiovascular diseases (CVD) mortality. However, greater mortality rate in these regions can be
justiﬁed by varying risk factors including different
genetics, lifestyle and healthcare service and other
additional factors. Despite greater CVD burden on
lower middle income countries like Pakistan [15],
limited data exists regarding predictors of mortality
of NSTEMI. We therefore evaluated predictors of 6months mortality of patients presenting with
NSTEMI at the largest cardiac care center of the
country, in effort to explore the factors which have a
major effect on mortality of NSTEMI patients in this
study.

2. Methods
For this prospective observational study we
recruited 300 adult patients, between 18 and 80
years of age, diagnosed as non-ST elevation acute
coronary syndrome (NSTE-ACS) at emergency
department of a tertiary care cardiac hospital of
Karachi, Pakistan between October 2019 and March
2020. Study was approved by the ethical review
committee of the institution (ERC-43/2019). Patients
with history of cardiac related intervention or surgery or patients who refused to give consent for
participation and follow-up were excluded.
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List of Abbreviations
CVD
cardiovascular diseases
ACS
acute coronary syndrome
AMI
acute myocardial infarction
NSTE-ACS
non-ST elevation acute coronary
syndrome
STEMI ST elevation myocardial infarction
GRACE global registry of acute coronary events
TIMI
thrombolysis in myocardial infarction
CI
conﬁdence interval
SD
standard deviation
OR
odds ratio

Diagnosis of NSTE-ACS was made based on history of typical chest pain, electrocardiogram (ECG)
changes, and rise of high-sensitivity troponin I as
per the guidelines. Patients’ clinical status at presentation, demographic data, risk proﬁle, and risk
stratiﬁcation scores such as TIMI and GRACE 2.0
scores were obtained. All the patients were
managed as per the clinical practice guidelines and
institutional protocols by consultant cardiologists.
All he patients were followed-up after six months
and survival status was recorded. Cases lost during
follow-up were excluded from the ﬁnal analysis.
Collected data were analyzed using IBM SPSS
(version 21). Patients' baseline characteristics such
as demographics, risk factors, hemodynamic parameters, functional class, and risk scores were
expressed as mean ± standard deviation (SD) or
frequency percentages (%) appropriately and
compared by the six-month survival status with the
help of t-test or Chi-square test. Univariate logistic
regression analysis was performed with six-month
mortality as dependent and patients’ baseline
characteristics as independent variables. After
removing clinically and statistically redundant variables in the presence of GRACE and TIMI score,
the explanatory variables for the multivariable logistic regression analysis were KILLIP class II-IV,
TIMI score of 4 or higher, and GRACE 2.0 score of
150 or higher to determine the predictors of shortterm (six-month) mortality. Results of the univariate
and multivariate logistic regression analysis are reported odds ratio (OR) along with its 95% conﬁdence interval. Statistical criteria for signiﬁcance
was p-value of 0.05 or lesser.

3. Results
A total of 300 NSTE-ACS were recruited for this
study, 6-months follow-up was successful for 280
patients with lose to follow-up rate of 6.7%. Baseline
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Table 1. Baseline demographic and clinical characteristics stratiﬁed by the survival status after six months of NSTE-ACS.
Characteristics

Total

Total (N)
280
Gender
Male
76.8% (215)
Female
23.2% (65)
Age (years)
58.19 ± 10.68
50 years
26.8% (75)
51e65 years
51.1% (143)
>65 years
22.1% (62)
KILLIP class at presentation
I
84.6% (237)
II
12.9% (36)
III
1.8% (5)
IV
0.7% (2)
Risk factors
Diabetes
41.8% (117)
Hypertension
84.6% (237)
Smoking
27.1% (76)
Family history of CAD
11.1% (31)
Dyslipidemia
14.6% (41)
Obesity
7.9% (22)
Sedentary lifestyle
30.7% (86)
Cardiac arrest
3.9% (11)
Heart Rate (bpm)
77.49 ± 13.98
SBP (mmHg)
121.04 ± 16.77
Serum creatinine (ng/dL)
1.48 ± 6.98
Troponin I (ng/dL)
6.74 ± 17.21
Electrocardiography (ECG) at presentation
T-wave Inversion
32.1% (90)
ST-segment depression
43.2% (121)
Wellens Sign
2.5% (7)
Nonspeciﬁc changes
14.6% (41)
Ejection Fraction (%) on echocardiography
30%
22.9% (64)
30e45%
35.4% (99)
>45%
41.8% (117)
TIMI Score
3.17 ± 0.86
TIMI Score 4
34.6% (97)
GRACE 2.0 Score
120.64 ± 33.1
GRACE Score 150
18.9% (53)

Outcome after 6 months

p-value

Survived

Expired

252

28

-

77.4% (195)
22.6% (57)
57.42 ± 10.05
27.4% (69)
53.6% (135)
19% (48)

71.4% (20)
28.6% (8)
65.11 ± 13.58
21.4% (6)
28.6% (8)
50% (14)

0.479

90.9% (229)
8.7% (22)
0% (0)
0.4% (1)

28.6% (8)
50% (14)
17.9% (5)
3.6% (1)

<0.001*

39.7% (100)
84.1% (212)
27.8% (70)
10.7% (27)
14.3% (36)
7.1% (18)
30.2% (76)
0.4% (1)
76.45 ± 13.01
121.16 ± 16.45
1.49 ± 7.36
6.63 ± 17.81

60.7% (17)
89.3% (25)
21.4% (6)
14.3% (4)
17.9% (5)
14.3% (4)
35.7% (10)
35.7% (10)
86.89 ± 18.54
119.89 ± 19.69
1.43 ± 0.67
7.77 ± 10.62

0.032*
0.473
0.474
0.568
0.612
0.183
0.545
<0.001*
<0.001*
0.705
0.970
0.740

32.9% (83)
43.3% (109)
2.4% (6)
13.5% (34)

25% (7)
42.9% (12)
3.6% (1)
25% (7)

0.394
0.968
0.702
0.102

19.8% (50)
34.9% (88)
45.2% (114)
3.1 ± 0.84
31.3% (79)
116.68 ± 30.16
14.3% (36)

50% (14)
39.3% (11)
10.7% (3)
3.86 ± 0.76
64.3% (18)
156.29 ± 37.38
60.7% (17)

<0.001*
0.647
<0.001*
<0.001*
<0.001*
<0.001*
<0.001*

<0.001*
0.001*

CAD ¼ coronary artery diseases, SBP ¼ Systolic blood pressure, GRACE ¼ Global Registry for Acute Coronary Events,
TIMI ¼ thrombolysis in myocardial infarction.
* Signiﬁcant at 5%.

demographic and clinical characteristics stratiﬁed
by the survival status after six months of NSTE-ACS
are presented in Table 1. Overall mortality rate after
six months of NSTE-ACS was 10.0% (28/280). Mean
age of the expired patients was signiﬁcantly higher
than that that of survived patients, 65.11 ± 13.58 vs.
57.42 ± 10.05 years; p < 0.001. Mortality rate was
signiﬁcantly higher among patients above 65 years
of age, 22.6% (14/62) vs. 6.4% (14/218); p < 0.001, as
compared to patient group between 18 and 65 years
of age. Killip class at presentation was found to be
associated with 6-months mortality with mortality
rate of 3.4% (8/237) vs. 46.5% (20/43); p < 0.001 in
patients with Killip class I and II to IV respectively.
Similarly, patients in cardiac arrest and patients

with diabetes were found to have signiﬁcantly
higher mortality rate with mortality rates of 14.5%
(17/117) vs. 6.7% (11/163); p ¼ 0.032 for diabetic and
non-diabetic patients and 90.9% (10/11) vs. 6.7% (18/
269); p < 0.001 for patients with and without cardiac
arrest respectively.
Left heart catheterization (LHC) ﬁndings and
management strategy stratiﬁed by the survival status after six months of NSTE-ACS are presented in
Table 2. LHC was performed in 99 (35.4%) patients
and subsequently percutaneous coronary interventions (PCI) was performed in only 38 (13.6%)
patients while remaining 86.4% of the patients
received medical treatment. Among patients who
undergone LHC, diseased left main (LM) and

Table 2. Left heart catheterization ﬁndings and management strategy stratiﬁed by the survival status after six months of NSTE-ACS.
Characteristics

Total

Total (N)
Left heart catheterization done
Number of diseases vessels
Normal
Single vessel (SVD)
Two vessel (2VD)
Three vessel (3VD)
Involved vessel
Left main
Left anterior descending artery (LAD)
Right coronary artery (RCA)
Left circumﬂex (LCx)
Obtuse marginal (OM)
None
Management Strategy
Medical treatment
PCI done
Access site
Radial
Femoral
PCI vessel
LAD
LCx
LM to LAD
LCx and RCA
RCA
SVG-OM and LCx

Outcome after 6 months

p-value

Survived

Expired

280
35.4% (99)

252
35.3% (89)

28
35.7% (10)

0.967

2% (2)
26.3% (26)
16.2% (16)
55.6% (55)

2.2% (2)
27% (24)
18% (16)
52.8% (47)

0% (0)
20% (2)
0% (0)
80% (8)

0.336

11.1% (11)
86.9% (86)
66.7% (66)
68.7% (68)
4% (4)
2% (2)

9% (8)
85.4% (76)
67.4% (60)
67.4% (60)
2.2% (2)
2.2% (2)

30% (3)
100% (10)
60% (6)
80% (8)
20% (2)
0% (0)

0.045*
0.195
0.637
0.416
0.007*
0.632

86.4% (242)
13.6% (38)

85.3% (215)
14.7% (37)

96.4% (27)
3.6% (1)

0.103

86.8% (33)
13.2% (5)

89.2% (33)
10.8% (4)

0% (0)
100% (1)

0.009*

57.9% (22)
7.9% (3)
2.6% (1)
2.6% (1)
26.3% (10)
2.6% (1)

59.5% (22)
8.1% (3)
2.7% (1)
2.7% (1)
27% (10)
0% (0)

0% (0)
0% (0)
0% (0)
0% (0)
0% (0)
100% (1)

e

PCI ¼ percutaneous coronary interventions, SVG ¼ saphenous vein graft.
* Signiﬁcant at 5%.

obtuse marginal (OM) were more common in
expired cohort as compared to survived cohort. Sixmonth mortality rate was relatively higher for
medically treated patients as compared to the

patients who underwent PCI (11.2% (27/242) vs.
2.6% (1/38); p ¼ 0.103).
Odds ratios (OR) of mortality after six months of
NSTE-ACS by various clinical characteristics in
multivariate and univariate logistic regression

Table 3. Odds ratios (OR) of multivariate and univariate logistic regression analysis for mortality after six months of NSTE-ACS.
Parameters

Univariate

Multivariate

OR [95% CI]

p-value

OR [95% CI]

p-value

Female
>65 years
Heart Rate (per 5 bpm)
Serum creatinine (ng/dL)
Troponin I (ng/dL)
Cardiac arrest
KILLIP class II-IV
Diabetes
Hypertension
Family history of CAD
Dyslipidemia
Smoking
Obesity
PCI done
TIMI Score 4
GRACE 2.0 Score 150

1.37 [0.57e3.27]
4.27 [1.9e9.58]
1.25 [1.1e1.41]
1 [0.94e1.06]
1 [0.99e1.02]
139.44 [16.9e1150.78]
68.45 [7.88e594.41]
2.35 [1.06e5.22]
1.57 [0.45e5.46]
1.39 [0.45e4.3]
1.3 [0.47e3.65]
0.71 [0.28e1.82]
2.17 [0.68e6.93]
0.22 [0.03e1.63]
3.94 [1.74e8.93]
9.27 [4.02e21.4]

0.481
<0.001*
<0.001*
0.971
0.743
<0.001*
<0.001*
0.036*
0.476
0.569
0.613
0.475
0.192
0.137
0.001*
<0.001*

e
e
e
e
e
32.93 [2.65e408.8]
e
e
e
e
e
e
e
e
3.42 [1.35e8.66]
8.43 [3.33e21.38]

e
e
e
e
e
0.007*
e
e
e
e
e
e
e
e
0.009*
<0.001*

OR ¼ odds ratio, CI ¼ conﬁdence interval, CAD ¼ coronary artery diseases, GRACE ¼ Global Registry for Acute Coronary Events,
TIMI ¼ thrombolysis in myocardial infarction.
* Signiﬁcant at 5%.
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analysis are presented in Table 3. On univariate
analysis age above 65 years, increased heart rate,
cardiac arrest at presentation, Killip class II-IV at
presentation, and diabetes were found to be associated with increased risk of 6-months mortality
with OR [95% CI] of 4.27 [1.9e9.58], 1.25 [1.1e1.41],
139.44 [16.9e1150.78], 68.45 [7.88e594.41], and 2.35
[1.06e5.22] respectively. Risk stratiﬁcation based on
TIMI score with cutoff of 4 had OR of 3.94
[1.74e8.93] with mortality rate of 18.6% (18/97) vs.
5.5% (10/183); p < 0.001 for patients with TIMI score
4 and < 4 respectively. Similarly, risk stratiﬁcation
based on GRACE score with cutoff of 150 had OR
of 9.27 [4.02e21.4] with mortality rate of 32.1% (17/
53) vs. 4.8% (11/227); p < 0.001 for patients with
GRACE 2.0 score 150 and < 150 respectively. On
multivariable analysis KILLIP class II-IV, TIMI
Score 4 and GRACE 2.0 score 150 were found to
be independent predictors of mortality after six
months of NSTE-ACS with adjusted OR of 32.93
[2.65e408.8], 3.42 [1.35e8.66], and 8.43 [3.33e21.38]
respectively.

4. Discussion
This study is the ﬁrst to investigate the predictors
of 6-months mortality in a relatively large number of
NSTE-ACS patients hospitalized in tertiary cardiac
care center in Pakistan. The observed predictors in
this study were similar to the ones found in the large
acute myocardial infarction registries of western
regions like USA and Europe. Here we observed
several baseline characteristics such as age, KILLIP
class, diabetes, cardiac arrest, heart rate, TIMI score
and GRACE 2.0 score to be signiﬁcant (p  0.05)
predictors of 6-months mortality of patients presenting with NSTEMI.
In our study, mortality rate for the patients with
NSTE-ACS at 6-month was observed to be 10.0%,
data on post discharge outcome of these patients is
scarce, especially for South Asian Region. A study
based on Korea Acute Myocardial Infarction Registry by Kim HK et al. [16] reported one year mortality
rate of 14.3% after NSTEMI. A study conducted by
Chehab O et al. [17] in Beirut, Lebanon, reported inhospital mortality rate of 7.6% for NSTEMI patients.
In several AMI trials, elderly age has been a
constant mortality predictor. In a study by Goldberg
et al. found that the probability of mortality was
more than 10-fold greater proportionally with patients over 85 years of age than with patients aged
between 55 and 64 [18]. Similar results can be found
in studies by Chehab, Omar et al. [17] and Rosengren et al. [19]. These ﬁndings are in consistent
with the result of our study, where age more than 65

years old proves to be a signiﬁcant mortality predictor. One possible explanation for this is that
elderly people are expected to have more severe
heart disease, but they are less likely to undergo the
same intense care in revascularization and antiischemic therapy procedures than younger patients
[19e22].
In terms of multivariate analysis, cardiac arrest at
presentation and GRACE risk score above 150 were
found to be strong independent predictors of mortality of NSTE-ACS. The recommendations of the
European Society of Cardiology (ESC) have
emphasized the importance of cardiac arrest in the
treatment of patients with AMI due to their high risk
association [23] This ﬁnding is in consistent with a
study by Chen, Ying-Hwa et al., which concluded
both risk score models (TIMI and GRACE) having
high discriminatory accuracy in predicting both
short and long-term mortality for ACS, including
NSTEMI group of patients [24].
Moreover, our analysis demonstrates KILLIP class
II-IV, and prior history of diabetes as the only risk
factor, to be signiﬁcant predictors of mortality for 6months of NSTEMI. This result can be compared
with a study by Kim, Hyun Kuk et al. [16]. For more
than 50 years, Killip class was known as a signiﬁcant
mortality predictor [25]. Diabetes accounts for 1.6
million deaths annually worldwide [26], where diabetes being one of the most prevalent noncommunicable diseases in Pakistan, with up to
11.7% of the adult population living with it [27].
There are certain limitations in the study which
we cannot overlook upon. Firstly, this is a single
center study conducted at a tertiary care cardiac
center of Pakistan, therefore its results cannot be
generalized to the whole region. To accurately
evaluate the predictors of mortality for NSTEMI
patients, data should be collected from multiple
settings from different regions. Secondly, being a
prospective study, there were few losses of follow
up data which could result in biasness. Thirdly, we
did not consider therapeutic interventions or prescribed medications in our parameters, which may
have certain impact on the mortality rate for patients in our setting. Additional studies must be
carried out to remove these limitations and gain
further insight to the predictors of mortality of
NSTEMI patients.

5. Conclusion
In conclusion, our study demonstrates various
clinical parameters as predictors of 6-months mortality for patients presenting with NSTE-ACS. These
included age, KILLIP class, diabetes, cardiac arrest,

heart rate, TIMI score and GRACE score. With prior
knowledge of the signiﬁcance of mortality predictors, this may prove to be a life-saving tool in
cardiac care settings, where it would aid clinicians to
reduce the mortality rate in patients presenting with
NSTEMI.
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